Free Trial

Oculis (OCS) SEC Filings & 10K Form

Oculis logo
$19.06 +0.50 (+2.69%)
Closing price 10/7/2025 04:00 PM Eastern
Extended Trading
$19.06 0.00 (-0.01%)
As of 10/7/2025 05:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Oculis SEC Filings

DateFilerForm TypeView
10/06/2025
3:40 PM
Oculis (Filer)
Oculis Holding AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/23/2025
3:56 PM
Oculis (Subject)
Oculis Holding AG (Subject)
Sherif Riad (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/21/2025
3:30 PM
Oculis (Filer)
Oculis Holding AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/01/2025
3:05 PM
Oculis (Filer)
Oculis Holding AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/11/2025
3:35 PM
Oculis (Filer)
Oculis Holding AG (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
02/11/2025
5:52 AM
BVCF IV, L.P. (Filed by)
Oculis (Subject)
Oculis Holding AG (Subject)
Form SCHEDULE 13G/A
01/03/2025
3:45 PM
Brunnur vaxtarsjodur slhf (Filed by)
Oculis (Subject)
Oculis Holding AG (Subject)
Form SCHEDULE 13G/A
12/09/2024
8:43 PM
Oculis (Subject)
Oculis Holding AG (Subject)
Pivotal bioVenture Partners Fund I, L.P. (Filed by)
Form SC 13G
11/29/2024
12:05 PM
Oculis (Filer)
Oculis Holding AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:OCS) was last updated on 10/8/2025 by MarketBeat.com Staff
From Our Partners